Atraric acid

Cat. No.: IBDI-430668

Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases.

Product Details

Target	Androgen Receptor | NO Synthase | p38 MAPK | NF-κB
Molecular Weight	196.20
Appearance	Solid
Synonyms	Methyl atrarate
SMILES	O=C(OC)C1=C(C)C=C(O)C(C)=C1O
Structure Classification	Phenols
Purity	99.94%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.